Bioequivalence of a generic slow-release theophylline tablet in children.

[1]  L. Hendeles,et al.  Therapeutic Equivalence of a Generic Slow‐Release Theophylline Tablet , 1995, Pharmacotherapy.

[2]  D. Spangler.  Pharmacists' substitution of slow release theophylline products. Committee on Drugs, American College of Allergy and Immunology. , 1991, Annals of allergy.

[3]  R. Dockhorn,et al.  Pharmacist substitution of slow-release theophylline products. , 1989, The Journal of allergy and clinical immunology.

[4]  T. DeNapoli,et al.  Clinical relevance of the substitution of different brands of sustained-release theophylline. , 1988, The Journal of allergy and clinical immunology.

[5]  G. Milavetz,et al.  Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma. , 1986, The Journal of pediatrics.

[6]  M. Jolley.  Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. , 1981, Journal of analytical toxicology.

[7]  L. Hendeles,et al.  Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. , 1981, The Journal of pediatrics.

[8]  Laurie J. Smith,et al.  Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. , 1979, The Journal of allergy and clinical immunology.

[9]  L. Hendeles,et al.  Disposition of theophylline after a single intravenous infusion of aminophylline. , 1978, The American review of respiratory disease.

[10]  M. Weinberger,et al.  Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn. , 1977, Pediatrics.

[11]  G. Levy,et al.  Pharmacokinetics of theophylline in children with asthma. , 1976, Pediatrics.